Medsenic
Who owns Medsenic?
Medsenic is a French Biotech company, now owned by BioSenic SA, which acquired it in 2025 from JMYX Holding.
Capital Grand Est is still listed as an investor in Medsenic, status not confirmed after the 2025 sale.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods · co-invest detected
JMYX Holding sold MedSenic to BioSenic SA in 2025 after 9 years.
More from Cap Innov'Est 1
Other portfolio companies in the same fund.
France
FranceFrance· 2020France· 2019
France· 2018France· 2017More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Medsenic?
Medsenic is now owned by BioSenic SA, which acquired it in 2025 from JMYX Holding. Capital Grand Est is still listed as an investor in Medsenic, status not confirmed after the 2025 sale.
When did BioSenic SA acquire Medsenic?
BioSenic SA acquired Medsenic in 2025, buying from JMYX Holding.
Who did Medsenic sell to?
JMYX Holding sold Medsenic to BioSenic SA in 2025 (Trade Sale).
Who has owned Medsenic over time?
Medsenic has been through 2 private-equity ownership periods: JMYX Holding · via JMYX Holding Evergreen · 2016–2025 · sold to BioSenic SA · (Trade Sale); Capital Grand Est · via Cap Innov'Est 1 · since 2016.